Long-term effectiveness of electroconvulsive therapy in adolescents with schizophrenia spectrum disorders

Verfasser / Beitragende:
[Itziar Flamarique, Inmaculada Baeza, Elena de la Serna, Alexandre Pons, Miguel Bernardo, Josefina Castro-Fornieles]
Ort, Verlag, Jahr:
2015
Enthalten in:
European Child & Adolescent Psychiatry, 24/5(2015-05-01), 517-524
Format:
Artikel (online)
ID: 605477450
LEADER caa a22 4500
001 605477450
003 CHVBK
005 20210128100401.0
007 cr unu---uuuuu
008 210128e20150501xx s 000 0 eng
024 7 0 |a 10.1007/s00787-014-0602-3  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s00787-014-0602-3 
245 0 0 |a Long-term effectiveness of electroconvulsive therapy in adolescents with schizophrenia spectrum disorders  |h [Elektronische Daten]  |c [Itziar Flamarique, Inmaculada Baeza, Elena de la Serna, Alexandre Pons, Miguel Bernardo, Josefina Castro-Fornieles] 
520 3 |a To compare a sample of adolescents with schizophrenia spectrum disorders (SSD) treated with either ECT or antipsychotics (AP) alone at long-term follow-up. Patients diagnosed with SSD (n=21) treated with ECT due to resistance to AP or catatonia under the age of 18years (ECT group), were compared to a randomly selected group of patients with SSD treated only with AP (non-ECT group) (n=21) and matched for age, gender, diagnosis and duration of illness. Baseline data were gathered retrospectively from medical records. Subjects were assessed at follow-up (mean of follow-up period=5.5years; range 2-9years) using several clinical scales such as the Positive and Negative Syndrome Scale (PANSS), the Clinical Global Impression Scale (CGI) and the Global Assessment of Functioning (GAF). Improvement in PANSS positive, negative, general, total and CGI and GAF scores between baseline and follow-up assessment did not differ significantly between groups. At follow-up, no differences were observed for the PANSS negative, CGI and GAF scores between groups, but patients in the ECT group still had higher PANSS total, positive and general scores. ECT treatment followed by AP medication in treatment-resistant SSD or catatonia is at least as effective in the long term as AP alone in non-resistant patients. 
540 |a Springer-Verlag Berlin Heidelberg, 2014 
690 7 |a Schizophrenia  |2 nationallicence 
690 7 |a Electroconvulsive therapy  |2 nationallicence 
690 7 |a Adolescents  |2 nationallicence 
690 7 |a Psychosis  |2 nationallicence 
690 7 |a Catatonia  |2 nationallicence 
700 1 |a Flamarique  |D Itziar  |u Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari de Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain  |4 aut 
700 1 |a Baeza  |D Inmaculada  |u Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari de Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain  |4 aut 
700 1 |a de la Serna  |D Elena  |u Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari de Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain  |4 aut 
700 1 |a Pons  |D Alexandre  |u Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain  |4 aut 
700 1 |a Bernardo  |D Miguel  |u Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain  |4 aut 
700 1 |a Castro-Fornieles  |D Josefina  |u Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari de Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain  |4 aut 
773 0 |t European Child & Adolescent Psychiatry  |d Springer Berlin Heidelberg  |g 24/5(2015-05-01), 517-524  |x 1018-8827  |q 24:5<517  |1 2015  |2 24  |o 787 
856 4 0 |u https://doi.org/10.1007/s00787-014-0602-3  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s00787-014-0602-3  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Flamarique  |D Itziar  |u Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari de Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Baeza  |D Inmaculada  |u Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari de Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a de la Serna  |D Elena  |u Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari de Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Pons  |D Alexandre  |u Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bernardo  |D Miguel  |u Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Barcelona, Spain  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Castro-Fornieles  |D Josefina  |u Department of Child and Adolescent Psychiatry and Psychology, SGR1119, Institut Clinic de Neurociències, Hospital Clínic Universitari de Barcelona, C/Villarroel, 170, 08036, Barcelona, Spain  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t European Child & Adolescent Psychiatry  |d Springer Berlin Heidelberg  |g 24/5(2015-05-01), 517-524  |x 1018-8827  |q 24:5<517  |1 2015  |2 24  |o 787